Emmanuel Bachy, MD, PhD¹, Bernard Drenou, MD^2*, Fabrice Jardin, MD, PhD^3*, Keiko Nakajima, MD, MSc^4*, Katell Le Du, MD^5*, Gandhi Damaj, MD, PhD^6*, Fontanet Bijou, MD⁷, Borhane Slama, MD^8*, Gian Matteo Pica, MD^9*, Gaetan Vanstraelen^10*, Charles Herbaux, MD, PhD^11*, Roch Houot, MD, PhD^12*, Francois Lemonnier^13*, Julie Gay^14*, Pierre Sujobert, MD, PhD^15*, Marguerite Fournier^16*, Marlene Ochmann, MD^17*, Romain Guieze, MD, PhD^18*, Jorge Zeron^19*, Alexandra Traverse-Glehen, MD, PhD^20*, Jean Marc Schiano De Colella, MD^21* and Franck Morschhauser, MD, PhD²²

¹Hematology Department, Lyon Sud Hospital, Pierre-Bénite, France
²HôPital Emile Muller, Mulhouse Cedex 1, FRA
³Department of Hematology, Centre Henri Becquerel, Rouen, France
⁴Daiichi Sankyo Inc., Basking Ridge, NJ
⁵CLINIQUE VICTOR HUGO, LE MANS, FRA
⁶Hematology Institute, University Of Caen Normandie Hospital Center, Caen, France
⁷Institut Bergonié, Bordeaux, France
⁸Department of Hematology, Avignon Hospital Center, Avignon, France
⁹Département d'Hématologie, CH Chambery, Chambéry, France
¹⁰CHR VERVIERS - LA TOURELLE, Verviers, BEL
¹¹Centre Hospitalier Universitaire de Montpellier, Montpellier, France
¹²Rennes university hospital - Hospital Pontchaillou, Rennes, France
¹³Department of Hematology, Henri Mondor Hospital, CRETEIL, France
¹⁴CH Côte basque, Bayonne, FRA
¹⁵Laboratory of Hematology, Centre Hospitalier Lyon Sud, Pierre Bénite, France
¹⁶LYSARC, Pierre-Benite, France
¹⁷Hematology Department, CHU Orléans, Orléans, France
¹⁸CHU Estaing, Clermont Ferrand, FRA
¹⁹Daiichi Sankyo, Belmont, MA
²⁰Hospices Civils de Lyon/Université Lyon 1, CHU Lyon-Sud, Pathology Department, Lyon, France
²¹Institut Paoli-Calmettes, Marseille, France
²²CHU de Lille, Lille, France

Julie M. Vose, MD, MBA¹, Chan Y. Cheah, MBBS, DMSc^2*, Michael Roost Clausen, MD, PhD^3*, David Cunningham, MD, FRCP, FMedSci^4*, Umar Farooq, MD⁵, Tatyana Feldman, MD^6*, Herve Ghesquieres, MD, PhD^7*, Wojciech Jurczak, MD, PhD⁸, Kim Linton^9*, Catherine Thieblemont, MD¹⁰, Tycel J. Phillips, MD¹¹, Won Seog Kim, MD, PhD^12*, Pegah Jafarinasabian, MD, PhD^13*, Barbara D'Angelo Månsson, PhD^14*, David Soong, PhD^15*, Andrew J. Steele, PhD^15*, Zhu Li, MS^15*, Christian Eskelund, MD, PhD^15*, Martin Hutchings, MD, PhD¹⁶ and Yasmin H. Karimi, MD¹⁷

¹University of Nebraska Medical Center, Omaha, NE
²Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia
³Vejle Hospital, Vejle, Denmark
⁴Royal Marsden NHS Foundation Trust, London, United Kingdom
⁵University of Iowa, Iowa City, IA
⁶John Theurer Cancer Center at Hackensack Meridian Health, HMH School of Medicine, Hackensack, NJ
⁷Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁸MSC National Research Institute of Oncology, Kraków, Poland
⁹The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
¹⁰Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, France
¹¹University of Michigan Comprehensive Cancer Center (present affiliation: City of Hope, Duarte, CA), Ann Arbor, MI
¹²Samsung Medical Center, Seoul, Korea, Republic of (South)
¹³AbbVie Inc, North Chicago, IL
¹⁴Genmab, Copenhagen, Denmark
¹⁵Genmab, Plainsboro, NJ
¹⁶Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
¹⁷Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI

Ting Xie^1*, Wei Liu^2*, Wenyang Huang, MD^3*, Huimin Liu^4*, Weiwei Sui, MD^5*, Yi Wang^3*, Wenjie Xiong^5*, Yan Xu^2*, Lugui Qiu⁵ and Dehui Zou^3*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjing, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁴Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Tianjin, China
⁵State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Ying Fang^1*, Weili Zhao^2,3,4 and Wang Li, MD^5*

¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
²Chinese‐French Research Center in Living Science and Genomics, Laboratory of Molecular Pathology, Shanghai, China
³Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
⁴Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, SHANGHAI, CHN
⁵Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Shanghai, China

Nancy L. Bartlett, MD¹, Jeong-A Kim², Uwe Hahn^3*, Isabelle Fleury, MD, MSc⁴, Kamel Laribi^5*, Juan Miguel Bergua Burgues, MD^6*, Craig A. Portell^7*, Melina Boutin^8*, Blanca Sanchez Gonzalez^9*, Selay Lam^10*, Sung Yong Oh^11*, Judit Mészáros Joergensen, MD, PhD^12*, Young Rok Do, MD, PhD¹³, Herve Ghesquieres, MD, PhD^14*, Grzegorz S. Nowakowski, MD¹⁵, Christopher Yasenchak, MD¹⁶, Monica Patterson^17*, Linda Ho^17*, Evelyn Rustia^17*, Michelle Fanale^18*, Keenan Fenton^17* and Vincent Ribrag, MD¹⁹

¹Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
²St. Vincent Hospital, The Catholic University of Korea, Suwon, South Korea
³Royal Adelaide Hospital, Adelaide, Australia
⁴CIUSSS de L'Est de l'lle de Montreal / installation Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
⁵Hématologie Clinique, CH Le Mans, Le Mans, France
⁶Hospital San Pedro de Alcántara, Caceres, Spain
⁷UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA
⁸CISSS de la Monteregie-Centre, Longueuil, QC, CAN
⁹Hematology Department, Hospital del Mar, Barcelona, Spain
¹⁰London Health Sciences Centre - Victoria Hospital, London, Canada
¹¹Dong-A University Hospital, Busan, Korea, Republic of (South)
¹²Aarhus University Hospital, Aarhus, Ethiopia
¹³Department of Hemato-Oncology, Dongsan Medical Center, Keimyung University, Daegu, Korea, Republic of (South)
¹⁴Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
¹⁵Mayo Clinic, Rochester, MN
¹⁶Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
¹⁷Pfizer Inc., Bothell, WA
¹⁸Pfizer, New York, NY
¹⁹Institut Gustave Roussy, Villejuif, France

Geoffrey Shouse, PhD, DO¹, Leslie Popplewell^2*, Alex Muir, RN, BSN^1*, Tanya Siddiqi, MD³, Jasmine Zain, MD⁴, Alex F. Herrera, MD⁵, Olga Danilova, MD, PhD^4*, Stephen E Spurgeon, MD⁶, Lili Wang, MD, PhD⁷, Adam S Kittai, MD⁸, Lu Chen^4*, Matthew S. Davids, MD, MMSc⁹ and Alexey V. Danilov, MD, PhD¹⁰

¹City of Hope National Medical Center, Duarte, CA
²Medical Director HCT and Cellular Therapy Atlanta, Atlanta, Atlanta, Georgia
³Department of Hematology, City of Hope, Irvine, CA
⁴City of Hope, Duarte, CA
⁵Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁶Knight Cancer Institute, Oregon Health & Science University, Portland, OR
⁷Department of Systems Biology, City of Hope, Duarte, CA
⁸Division of Hematology, The Ohio State University, Columbus, OH
⁹Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
¹⁰City of Hope National Medical Center, La Canada Flintridge, CA

Kurt S. Bantilan, MPH^1*, Efrat Luttwak, MD¹, Craig H. Moskowitz, MD², Matthew Matasar, MD, MS³, David J. Straus, MD¹, Carol S. Portlock, MD^1*, Alison Moskowitz, MD¹, Ariela Noy, MD¹, Maria Lia Palomba, MD¹, Steven Horwitz, MD¹, Gilles Salles, MD, PhD⁴, Colette Owens, MD¹, Pallawi Torka, MD⁵, Alexander P. Boardman, MD^1*, Kevin A. David, MD^1*, Zachary D. Epstein-Peterson, MD¹, Anita Kumar, MD⁶, Philip Caron, MD¹, Paola Ghione, MD, MSEpi⁷, Lorenzo Falchi, MD⁷, Jennifer K Lue, MD¹, Raphael Steiner, MD^1*, Robert Stuver, MD¹, Ahmet Dogan, MD, PhD⁷, Paul A. Hamlin, MD¹ and Andrew D. Zelenetz, MD, PhD¹

¹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
³Division of Blood Disorders, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New York, NY
⁴Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Lymphoma Service, Department of Medicine, MSKCC, New York, NY
⁶Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
⁷Memorial Sloan Kettering Cancer Center, New York, NY

Sabarish Ayyappan¹, H. Miles Prince, MD, MBBS², Cecilia Carpio^3*, Isidro Jarque^4*, Srikanth Ambati⁵, Chinjune Lin⁵, Hesham Mohamed⁵, Giovanni Antico^5*, C. Akunna Otele^5* and Jan Walewski^6*

¹City of Hope Cancer Center Atlanta, Newnan, GA
²Epworth HealthCare and University of Melbourne, Melbourne, VIC, Australia
³Department of Hematology, University Hospital Vall d'Hebron, Barcelona, Spain
⁴Hematology Department, Hospital Universitari i Politècnic La Fe, Centro de Investigación Biomédica en Red de Cáncer – CIBERONC, Valencia, Spain
⁵Regeneron Pharmaceuticals, Inc., Tarrytown, NY
⁶Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warszawa, Poland

Chunmei Yang^1*, Juying Wei^1*, Ying Lu^2*, Liping Mao, M.D.^1*, Min Yang, M.D.^3*, Huafeng Wang^1*, De Zhou, M.D.^3*, Hongyan Tong, PhD¹, Jie Jin, M.D.⁴ and Wen-Juan Yu^1*

¹Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Department of Hematology, Yinzhou People's Hospital, Ningbo, China
³Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁴Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Jie Wang^1*, He Li^2*, Chenlu Yang^2*, Di Wu^3*, Xingli Zou^4*, Tao Yang^5*, Liangliang Ma^6*, Fang Xu^7*, Jie Wang^3*, Minggang Su^2*, Sha Zhao^2*, Lin Ji^2*, Yao Liu⁵, Pengcheng He^8* and Ting Niu, MD, PhD⁹

¹Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
²West China Hospital, Sichuan University, Chengdu, China
³The First Affiliated Hospital of Xi'an Jiaotong University, Xi'An, China
⁴Affiliated Hospital of North Sichuan Medical college, Nanchong, China
⁵Chongqing University Cancer Hospital, Chongqing, China
⁶Dapartment of Hematology,Meishan People's Hospital, Meishan, China
⁷Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, China
⁸Department of Hematology, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China
⁹National Facility for Translational Medicine (Sichuan), West China Hospital, Sichuan University, Chengdu, China

Uwe Hahn^1*, Nancy L. Bartlett, MD², Jeong-A Kim³, Krimo Bouabdallah, MD^4*, Nicholas Forward^5*, Tsai-Yun Chen^6*, Vincent Camus, MD, PhD^7*, Ming-Chung Wang^8*, Philippe Carassou^9*, Enrico Derenzini, MD, PhD^10*, Hung Chang^11*, Fritz Offner, MD, PhD¹², Herve Ghesquieres, MD, PhD^13*, Grzegorz S. Nowakowski, MD¹⁴, Christopher Yasenchak, MD¹⁵, Monica Patterson^16*, Linda Ho^16*, Evelyn Rustia^16*, Michelle Fanale^17*, Keenan Fenton^16* and Craig A. Portell^18*

¹Royal Adelaide Hospital, Adelaide, Australia
²Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
³St. Vincent Hospital, The Catholic University of Korea, Suwon, South Korea
⁴Bordeaux university hospital, Haut-Leveque, Department of hematology, Bordeaux, France
⁵Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada
⁶National Cheng Kung University Hospital Clinical Trial Center, Tainan, Taiwan
⁷Centre Henri Becquerel, Department of Hematology, Rouen, France
⁸Chang Gung Memorial Hospital, Kaohsiung, Taiwan
⁹Centre Hospitalier Regional Metz-Thionville, Hopital Mercy, Metz, France
¹⁰European Institute of Oncology, Milan, Italy
¹¹Chang Gung Memorial Hospital, Taoyuan, Taiwan
¹²Universitair Ziekenhuis Gent, Gent, Belgium
¹³Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
¹⁴Mayo Clinic, Rochester, MN
¹⁵Willamette Valley Cancer Institute and Research Center/US Oncology Research, Eugene, OR
¹⁶Pfizer Inc., Bothell, WA
¹⁷Pfizer, New York, NY
¹⁸UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA

Ying Zhang^1*, Wei Guo, MD/PhD^1*, Yangzhi Zhao, MD/PhD^1*, Zhumei Zhan^2*, Haotian Wang^3*, Zhe Li^4*, Bowen Wang^5*, Luming Cao, MD^3*, Xin Wan, MD^6*, Jia Li¹ and Ou Bai, MD/PhD^3*

¹Department of Hematology, The First Hospital of Jilin University, Changchun, China
²Department of Hematology, Shandong First Medical University, Jinan, China
³The First Hospital of Jilin University, Changchun, China
⁴First Hospital of Jilin University, Changchun, China
⁵The first Hosptial of Jilin University, Changchun, China
⁶Department of Hematology, The First Hospital of Jilin University, Changchun, Jilin, China

Catherine Thieblemont, MD¹, Yasmin H. Karimi, MD², Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc³, Michael Roost Clausen, MD, PhD^4*, Kim Linton^5*, Tycel J. Phillips, MD⁶, Franck Morschhauser, MD, PhD⁷, Martin Hutchings, MD, PhD⁸, Rebekah Conlon, BN^9*, Saurabh Mukhopadhyay^10*, Aurelie Le Maitre^11*, Yu Deng, PhD^10*, Mariana Sacchi, MD^12*, Thomas Doerr, MSc^10*, Minh Dinh, MD^9*, William Palo^10* and Loretta Nastoupil^13*

¹Department of Hematology, Assistance Publique Hôpitaux de Paris - Hopital Saint-Louis, University of Paris, Paris, France
²Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
³Department of Haematology, Sir Charles Gairdner Hospital and the University of Western Australia, Nedlands, Australia
⁴Vejle Hospital, Vejle, Denmark
⁵The Christie NHS Foundation Trust, Manchester Cancer Research Centre, and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom
⁶City of Hope, Duarte, CA
⁷Centre Hospitalier Régional Universitaire de Lille, Lille, France
⁸Rigshospitalet and University of Copenhagen, Copenhagen, Denmark
⁹AbbVie Inc, North Chicago, IL
¹⁰AbbVie Inc., North Chicago, IL
¹¹Everest Clinical Research, Markham, ON, Canada
¹²Genmab, Plainsboro, NJ
¹³MD Anderson Cancer Center, Houston, TX

Zi-Yang Shi^1*, Qing Shi^2*, Weili Zhao^2,3* and Li Wang^3,4*

¹Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Nati, Shanghai, China
²Shanghai Institute of Hematology; State Key Laboratory of Medical Genomics; National Research Center for Translational Medicine at Shanghai; Department of Hematology, Shanghai Ruijin Hospital; Shanghai Jiao Tong University School of Medicine, Shanghai, China
³Pôle de Recherches Sino-Français en Science du Vivant et Génomique; Laboratory of Molecular Pathology, Shanghai, China
⁴Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China

Stephen Yu, MD, MS¹, Mohammed Abdulhaleem, MD² and Salah Ud Din Safi, MD^3*

¹Department of Medicine, Section of Hematology/Oncology, West Virginia University, Morgantown, WV
²Department of Internal Medicine, Division of Medical Oncology, West Virginia University, Morgantown, WV
³Department of Medical Oncology, West Virginia University Cancer Institute, Morgantown, WV

Chunmei Yang^1*, Ying Lu^2*, Juying Wei^1*, Lihong Shou^3*, Hongyan Tong, PhD¹, Jie Jin, M.D.¹ and Wenjuan Yu^1*

¹Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Department of Hematology, Yinzhou People's Hospital, Ningbo, China
³Department of Hematology, Huzhou Central Hospital, The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, China

Kudret Kama, MD^1*, Alexandra Kutilina, MD^2*, Julia Wendler, MD^1*, Hannes Treiber, MD^3*, Stefan Trefz, MD^1*, Jürgen Finke, MD⁴, Gerald Wulf^3*, Lisa Isbell, MD^2*, Aslihan Arslan^5*, Antje Jensch^5*, Elisabeth Schorb, MD^2* and Gerald Illerhaus, MD¹

¹Department of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany
²Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
³Department of Hematology and Medical Oncology, University Hospital Goettingen, Goettingen, Germany
⁴Department of Haematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, Department of Medicine I, Medical Center - University of Freiburg, Faculty of Medicine, Albert Ludwigs University (ALU), Freiburg, Germany, Freiburg, Germany, Freiburg, Germany
⁵Stuttgart Cancer Center, Klinikum Stuttgart, Stuttgart, Germany

Sha Zhou^1*, Jun Rao^2*, Xixi Xiang^3*, Yunjing Zeng^4*, Jiali Li^5*, Hanshan Yang^1*, Bo Liu^1*, Xi Zhang, PhD³ and Li Gao^6*

¹Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
²Medical center of hematology, Xinqiao Hospital, Army Medical University, Chongqing, China
³Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China
⁴Xinqiao Hospital, Army Medical University, Chongqing, CHN
⁵Xinqiao Hospital, Army Medical University, Chongqing, China
⁶Army medical University affiliated Xinqiao Hospital, Chongqing, China

Peter A. Riedell, MD^1*, Krish Patel, MD^2*, Vanessa Dunleavy, ARNP^3*, Yasmin H. Karimi, MD⁴, Nirav N. Shah, MD⁵, Vincent Ribrag, MD⁶, Loic Ysebaert, MD, PhD^7*, Robin Noel, MD^8*, Gabriel Brisou, MD, PhD^9*, Justin Kline, MD¹⁰, Chet Bohac, PharmD, MD, MSc^11*, Carlos Naranjo, MD, MPH^12*, Jitendra Kanodia, PhD^13*, Jacky Woo^12*, Nancy Chen^12*, Jean-Marie Michot, MD^14*, Benoîtt Tessoulin, MD, PhD^15* and Sairah Ahmed, MD¹⁶

¹University of Chicago Medicine, Chicago, IL
²Swedish Cancer Institute, Seattle, WA
³Swedish Cancer Institute, Center for Blood Disorders and Cellular Therapy, Seattle, WA
⁴Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
⁵Medical College of Wisconsin, Brookfield, WI
⁶Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France
⁷Hematology Department, Institut Universitaire du Cancer Toulouse Oncopole, Toulouse, France
⁸Institut Paoli-Calmettes, Marseille, FRA
⁹Institut Paoli-Calmettes, Marseille, France
¹⁰University of Chicago, Chicago, IL
¹¹Xencor, Inc, Pasadena, CA
¹²Xencor, Inc, San Diego, CA
¹³Xencor, San Diego, CA
¹⁴Institute Gustave Roussy, Villejuif, France
¹⁵Department of hematology, Nantes university hospital, Nantes, France
¹⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Konstantinos Christofyllakis^1*, Igor Age Kos, MD^1*, Bettina Altmann, PhD^2*, Viola Poeschel, MD^1*, Stephanie Maurer, MSc^1*, Vadim Lesan^1*, Jörg-Thomas Bittenbring, MD^1*, Dominic Kaddu-Mulindwa, MD^1*, Zanir Abdi^1*, Manfred Ahlgrimm, MD^3*, Sarah Altmeyer, MD^1*, Octavian Fleser, MD^1*, Gerhard Held, MD^4*, Maike Nickelsen, MD^5*, Martin Dreyling, MD⁶, Florian Zettl, MD^7*, Christian Buske, MD⁸, Georg Lenz⁹, Bertram Glass, MD^10*, Björn Chapuy¹¹, Norbert Schmitz, MD^9*, German Ott, MD^12*, Reiner Siebert, PhD^13*, Andreas Viardot, MD, PhD¹⁴, Florian Scherer, MD¹⁵, Roland Schmitz, PhD^16*, Andreas Rosenwald, MD^17*, Dirk Hellwig, MD^18*, Nina Neuendorff, MD^19*, Theodoros Vassilakopoulos^20*, Chrysoula Doxani, MD, MSc^21*, Pascal Blatt, MD^22*, Oguzhan Nakisli^1*, Susanne Schmidt, MD^1*, Tobias Gaska, MD²³, Börge Arndt, MD^24*, Matthias Mueller, MD^25*, Hanno Maximilian Witte, MD^25*, Martin Bentz, MD^26*, Volkmar Boehme, MD^5*, Heinz Kirchen, MD^23*, Markus Loeffler, MD^2*, Boris Kubuschock, MD^27*, Niklas Gebauer^28*, Rolf Mahlberg, MD^29*, Julian Topaly, MD^30*, Alexander Bott, MD^31*, Kai Wille, MD^32*, Ralf Ulrich Trappe, MD^33*, Mathias J. Rummel, MD^34*, Gerald Illerhaus, MD³⁵, Franziska Brunner, MD^36*, Martin Klump, MD^37*, Ulrich Kaiser, MD^38*, Swen Wessendorf, MD^39*, Iordanis Deligiannis, MD^23*, Bert Hildebrandt, MD^40*, Alexander Kiani, MD^41*, Thomas Illmer, MD^42*, Gabriele Prange-Krex, MD^43*, Kristina Lerch, MD^44*, Matthias Sandmann, MD^45*, Sebastian Broeckling, MD^46*, Uwe Martens, MD^47*, Bastian von Tresckow^48,49, Annkristin Heine, MD^50*, Holger F. Hebart, MD⁵¹, Stephan Stilgenbauer, MD^52,53, Lorenz Thurner, MD¹, Moritz Bewarder, MD^1* and Marita Ziepert, PhD^2*

¹Department of Oncology, Hematology, Clinical Immunology and Rheumatology, Saarland University Medical Center, Homburg/Saar, Germany
²Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany
³Department of Oncology, Hematology, Clinical, and Rheumatology, Saarland University Medical Center, Homburg/Saar, Germany
⁴Department of Internal Medicine 1, Westpfalz-Klinikum, Kaiserslautern, Germany
⁵Oncology Lerchenfeld, Hamburg, Germany
⁶Department of Internal Medicine III, Ludwig-Maximilian-University Munich, Munich, Germany
⁷Department of Hematology and Oncology, Klinikum Traunstein, Traunstein, Germany
⁸Institute of Experimental Cancer Research, University Hospital Ulm, Ulm, Germany
⁹Department of Medicine A, Hematology, Oncology and Pneumology, University Hospital Muenster, Muenster, Germany
¹⁰Department of Hematology, Oncology and Stem Cell Transplantation, Asklepios Klinik St. Georg, Hamburg, Germany
¹¹Department of Hematology, Oncology and Cancer Immunology, Charité - University Medical Center Berlin, Campus Benjamin Franklin, Berlin, Germany
¹²Department of Clinical Pathology, Robert-Bosch-Krankenhaus, and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany
¹³Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany
¹⁴Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
¹⁵Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
¹⁶Institute for Pathology, Molecular Cytology and Functional Genomics, University Hospital Giessen, Giessen, Germany
¹⁷Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany
¹⁸Department of Nuclear Medicine, University Hospital Regensburg, Regensburg, Germany
¹⁹Marien Hospital Herne-Universitätsklinikum der Ruhr-Universität Bochum, Herne, Germany
²⁰Department of Hematology and Bone Marrow transplantation Unit, National and Kapodistrian University of Athens, Laikon General Hospital, Athens, Greece
²¹Laboratory of Biomathematics, Department of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
²²Department of Oncology, Hematology, Clinical Immunology and Rheumatology, Saarland Universtity Medical Center, Homburg/Saar, Germany
²³Department Internal Medicine I, Krankenhaus der Barmherzigen Brüder, Trier, Germany
²⁴Department of Hematology and Oncology, Helios Klinikum Emil von Behring, Berlin, Germany
²⁵Department of Hematology and Oncology, Bundeswehr Krankenhaus Ulm, Ulm, Germany
²⁶Department Internal Medicine III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany
²⁷Department of Internal Medicine II, Augsburg University Medical Center and Comprehensive Cancer Center Augsburg, CCC Alliance WERA and Bavarian Cancer Research Center (BZKF), Augsburg, Germany
²⁸Department for Hematology and Oncology, University Hospital Schleswig-Holstein, Campus Luebeck, Luebeck, Germany
²⁹Internal Medicine I, Hospital Mutterhaus der Borromäerinnen, Trier, Germany, Trier, DEU
³⁰Department of Hematology and Oncology, Caritas Klinikum Saarbrücken, Saarbruecken, Germany
³¹Department of Internal Medicine V, Klinikum Nürnberg-Nord, Nuernberg, Germany
³²University of Bochum, University Clinic For Hematology and Oncology Minden, Bochum, Germany
³³Department of Internal Medicine III, DIAKO Ev. Diakonie-Krankenhaus, Bremen, Germany
³⁴Department of Haematology-Oncology, Giessen University Hospital, Giessen, Germany
³⁵Department of Hematology, Oncology, Stem-Cell Transplantation and Palliative Care, Klinikum Stuttgart, Stuttgart, Germany
³⁶Department of Internal Medicine IV, Hematology and Oncology, Martin Luther University Halle-Wittenberg, Halle, Germany
³⁷Department of Hematology and Oncology, Diakonie Klinikum Jung-Stilling, Siegen, Germany
³⁸36. Department of Hematology, Immunology and medical Oncology, St. Bernward Krankenhaus, Hildesheim, Germany
³⁹Cancer Center Esslingen, Klinikum Esslingen, Esslingen, Germany
⁴⁰Department of Internal Medicine I, Werner Forßmann Hospital, Eberswalde, Germany
⁴¹Department of Hematology and Oncology, Klinikum Bayreuth, Bayreuth, Germany
⁴²Hematology Private Practice, Dresden, Germany
⁴³Gemeinschaftspraxis Dr. med. Johannes Mohm, Dr. med. Gabriele Prange-Krex Dresden, Dresden, Germany
⁴⁴Onkologische Schwerpunktpraxis Kurfürstendamm, Berlin, Germany
⁴⁵Department of Internal Medicine III, Petrus-Krankenhaus, Wuppertal, Germany
⁴⁶Department of Internal Medicine VI, Mathias Hospital Rheine, Rheine, Germany
⁴⁷Hematology, Oncology, Palliative Care, SLK Clinic Heilbronn, Heilbronn, Germany
⁴⁸Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
⁴⁹Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
⁵⁰Department of Oncology, Hematology, Rheumatology and Immune-Oncology, University Hospital Bonn, Bonn, Germany
⁵¹Department of Internal Medicine, Hematology and Oncology, Stauferklinikum, Mutlangen, Mutlangen, Germany
⁵²Comprehensive Cancer Center Ulm, University of Ulm, Ulm, Germany
⁵³Department of Internal Medicine III, Division of CLL, University Hospital Ulm, Ulm, Germany

Paolo F. Caimi, MD¹, Allison M. Winter, MD¹, Robert M. Dean, MD², Taylor R. Brooks, MD¹, Deepa Jagadeesh, MD², Craig S. Sauter, MD¹ and Brian T. Hill, MD, PhD³

¹Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
³Department of Hematology and Medical Oncology, Taussig Cancer Institute, The Cleveland Clinic Foundation, Cleveland, OH

Lixia Sheng^1*, Guifang Ouyang^1*, Yanli Lai^1*, Sheng Nie^2*, Di Wang^3*, Shanhao Tang^1*, Yuning Pan^4*, Kaihong Xu^1*, Yongcheng Sun^1*, Ping Zhang^1*, Binbin Lai^1* and Lieguang Chen^1*

¹Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China
²Department of Neurosurgery, The First Affiliated Hospital of Ningbo University, Ningbo, China
³Department of Medical, Nanjing Geneseeq Technology Inc., Nanjing, China
⁴Department of Radiology, The First Affiliated Hospital of Ningbo University, Ningbo, China

Katharine L. Lewis^1,2,3, Wojciech Jurczak, MD, PhD⁴, Gareth P. Gregory, MBBS(Hons), PhD, FRACP, FRCPA⁵, Constantine S. Tam^6*, Won Seog Kim^7*, Eliza A. Hawkes, MD⁸, Franck Morschhauser⁹, Sarit E. Assouline, MD¹⁰, Geoffrey Shouse, PhD, DO¹¹, Petra Langerbeins^12*, Monica Tani^13*, Young Rok Do, MD, PhD¹⁴, Bruce D. Cheson¹⁵, Catherine S. Diefenbach, MD¹⁶, Craig A. Portell^17*, Jennifer Xavier^18*, Muhtarjan Osman^18*, Siminder K. Atwal^18*, Wan-Jen Hong¹⁸ and Clémentine Sarkozy^19*

¹Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
²University of Western Australia, Perth, Western Australia, Australia
³WA Linear Clinical Research, Nedlands, Western Australia, Australia
⁴Maria Skłodowska – Curie National Research Institute of Oncology, Kraków, Poland
⁵School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia
⁶Alfred Hospital and Monash University, Melbourne, VIC, Australia
⁷Samsung Medical Center, Seoul, Korea, Republic of (South)
⁸Olivia Newton John Cancer Research Institute at Austin Health and Monash University, Melbourne, VIC, Australia
⁹CHU de Lille - Hôpital Claude Huriez, Universitaire de Lille, Lille, France
¹⁰McGill University, Jewish General Hospital, Montreal, QC, Canada
¹¹City of Hope National Medical Center, Duarte, CA
¹²Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany
¹³Ospedale Santa Maria delle Croci, Ravenna, Italy
¹⁴Keimyung University Dongsan Hospital, Daegu, Korea, Republic of (South)
¹⁵American Oncology Partners PA, Bethesda, MD
¹⁶New York University, Perlmutter Cancer Center at NYU Langone Health, New York, NY
¹⁷University of Virgina, Charlottesville, VA
¹⁸Prelude Therapeutics Incorporated, Wilmington, DE
¹⁹Institut Curie, Saint-Cloud Hospital, Saint-Cloud, France

Emmanuel Bachy, MD, PhD¹, Tae Min Kim, MD, PhD^2*, Shang-Ju Wu^3*, Jan Walewski^4*, Jingxian Cai^5*, Nickolas Sophos, MS^5*, Aafia Chaudhry⁵, Hesham Mohamed⁵, Srikanth Ambati⁵ and H. Miles Prince⁶

¹Hospices Civils de Lyon and Université Claude Bernard Lyon, Lyon, France
²Seoul National University Hospital, Seoul, Korea, Republic of (South)
³Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
⁴Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie Państwowy Instytut Badawczy, Warszawa, Poland
⁵Regeneron Pharmaceuticals, Inc., Tarrytown, NY
⁶Epworth HealthCare and University of Melbourne, Melbourne, VIC, Australia